Sign Up to like & get
recommendations!
1
Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac375
Abstract: Coinfections are more common in patients with cystic fibrosis and bronchiectasis. Infiltrates on imaging studies are seen more commonly in patients with coinfections, but coinfections did not affect treatment outcomes of pulmonary Mycobacterium avium complex.
read more here.
Keywords:
mycobacterium avium;
treatment outcomes;
outcomes pulmonary;
pulmonary mycobacterium ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000519
Abstract: Purpose of review Pulmonary exacerbations are described as worsening of the daily symptoms of cystic fibrosis airways disease, typically with increased cough and sputum production. There are often associated signs such as weight loss and…
read more here.
Keywords:
cystic fibrosis;
treatment;
optimizing outcomes;
pulmonary exacerbations ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Thorax"
DOI: 10.1136/thorax-2022-219490
Abstract: The value placed by patients and their caregivers on the components of composite outcomes in pulmonary arterial hypertension (PAH) remains unknown. We surveyed the importance of these outcomes from a patients’ and caregivers’ perspective, with…
read more here.
Keywords:
arterial hypertension;
clinical trials;
pulmonary arterial;
perceptions clinical ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa4132
Abstract: Background: There’s a debate in the current literature about the utility of blood eosinophil count (EC) as a biomarker in COPD patients. Objectives: To evaluate if COPD patients have different outcomes in a Pulmonary Rehabilitation…
read more here.
Keywords:
pulmonary rehabilitation;
copd patients;
group;
copd ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202211_30160
Abstract: OBJECTIVE Pulmonary actinomycosis is a rare and chronic infectious disease that mimics malignancy and is frequently misdiagnosed. There are few reports that address the clinical characteristics of pulmonary actinomycosis. The objective of this research is…
read more here.
Keywords:
actinomycosis;
treatment outcomes;
pulmonary actinomycosis;
outcomes pulmonary ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Thoracic Medicine"
DOI: 10.4103/atm.atm_119_21
Abstract: BACKGROUND: Pulmonary inflammatory myofibroblastic tumor (PIMT) is an extremely rare disease. The aim of this study was to share the surgical outcomes of these tumors. METHODS: Patients who were operated for pulmonary myofibroblastic tumors between…
read more here.
Keywords:
treatment outcomes;
surgical treatment;
inflammatory myofibroblastic;
myofibroblastic tumors ... See more keywords